.jpg)
.png)
The Foundation of the National Lipid Association (FNLA) has been hard at work in the past few months, and we have many new initiatives and accomplishments to show for it.
Article By:
Associate Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Diplomate, American Board of Clinical Lipidology
Dr. Thomas Haffey’s passion for lipids shows in his dedication to the field. As a practicing cardiologist, he spends his days splitting time between seeing patients — a large part of which are dealing with lipid problems — and running research projects at North Suburban Medical Center. Out of office, he dedicates his time to the field of lipidology as well. Dr.
Article By:
Clinical Professor, Western University/COMP
Denver, CO
Diplomate, American Board of Clinical Lipidology
Greetings from the Southwest Lipid Association (SWLA)! Our geographic region extends from the gulf shores of Louisiana to the mountains of Colorado.
Article By:
Assistant Professor, University of Colorado
Colorado Springs, CO
Diplomate, American Board of Clinical Lipidology
Clinical Professor of Medicine, University of Arizona
Vice President, Scottsdale Cardiovascular Center
Scottsdale, AZ
Diplomate, American Board of Clinical Lipidology
Introduction
Article By:
OhioHealth Endocrinology Physicians
Columbus, OH
University of Colorado
Aurora, CO
University of Colorado
Aurora, CO
Diplomate, American Board of Clinical Lipidology
Approximately 27 percent of adult Americans have elevated (≥ 150 mg/ dL) fasting triglycerides (TG).1 This commonly encountered dyslipidemia is an important indicator of the presence of atherogenic lipoprotein particles and may be considered a modifiable risk factor for cardiovascular disease.2 While genetic defects are responsible for familial forms of hypertriglyceridemia, secondary causes of hypertriglyceridemia often can be attributed to dietary factors (e.g.
Article By:
Kaiser Permanente of Colorado
Clinical Assistant Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, CO
Diplomate, Accreditation Council of Clinical Lipidology
Kaiser Permanente of Colorado
Clinical Instructor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, CO
Disorders of the triglyceride-high-density lipoprotein (TG-HDL) axis, i.e. high TGs and low HDL cholesterol (HDL-C), are well documented in the medical literature,1 and are of particular importance to clinicians treating patients who are insulin resistant (IR) or who have diabetes mellitus (diabetes). We all see this in clinic ever y day, because there are now approximately 115 million Americans who are IR or who have diabetes.2
Article By:
Glendale, AZ
Private Practice
Scottsdale, AZ
The role of fibrates in treating patients with hyperlipidemia remains controversial.1-3 Recent randomized clinical trials of fibrates, alone or in combination with statins, have been inconclusive.4,5
Article By:
Texas Tech University Health Sciences Center
Lubbock, TX
Diplomate, American Board of Clinical Lipidology
Moderate elevation in triglyceride in the <500 mg/dl range frequently presents in children and adolescents,1 and is among risk factors associated with autopsy- proven atherosclerosis,2 whereas severe hypertriglyceridemia leading to pancreatitis is less common than in adults.
Article By:
University of Oklahoma Health Sciences Center
Oklahoma City, OK
Diplomate, American Board of Clinical Lipidology
Department of Internal Medicine, Division of Cardiology
Scott & White Healthcare
Temple, TX
Diplomate, American Board of Clinical Lipidology
Pediatric Endocrinology and Diabetes
Cook Children’s Medical Center
Fort Worth, TX
Diplomate, American Board of Clinical Lipidology
The American College of Cardiology (ACC) and the American Heart Association (AHA) — in collaboration with the National Heart, Lung and Blood Institute (NHLBI) — published their evidence- based hyperlipidemia guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular diseases (ASCVD).
Article By:
Endocrinologist
Eureka, CA
“With crown and mace and disc, a mass of effulgence gleaming everywhere, I see thee so dazzling to the sight, bright with splendor of the fiery sun blazing from all sides — incomprehensible!” ~ Translated from Chapter 11, Verse 17, Bhagavad Gita
Article By:
Clinical Professor of Medicine, University of Arizona
Scottsdale, AZ
Diplomate, American Board of Clinical Lipidology
Clinical Professor, Western University/COMP
Denver, CO
Diplomate, American Board of Clinical Lipidology